Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2025-12-24 @ 5:39 PM
NCT ID:
NCT03098368
Eligibility Criteria:
Inclusion Criteria:
* Patients: PD patients (age ≥ 18 years) who have history of nocturnal hypokinesia
* Patients not taking levodopa were eligible for study
* Patients who taking immediate- released levodopa,they had been on a stable dose for 28 days prior to baseline assessment and during the study
* Patients did not use control-released L-dopa at bedtime
Exclusion Criteria:
* History of narcolepsy, excessive daytime sleepiness, sudden onset of sleep
* History of hallucination, dementia and psychosis
* Evidence of ICDs
* Clinical relevant to cardiovascular disorders (including prolonged QTc ≥ 500 ms, recent MI)
* History of seizure or stroke in the past 1 year
* Patients had participated in other clinical trial in the past 28 days
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03098368
Study Brief:
Protocol Section:
NCT03098368